Neos Therapeutics, Inc. — Form D

Neos Therapeutics, Inc. of GRAND PRAIRIE, TX, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-09. The offering totals $20.0M, of which $13.6M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Christopher ClementDirectorGrand Prairie, TX
Karl HandelsmanDirectorGrand Prairie, TX
Dorothy FrankExecutive OfficerGrand Prairie, TX
Bryan HillExecutive OfficerGrand Prairie, TX
Margaret LokashExecutive OfficerGrand Prairie, TX
Mark Van AusdalExecutive OfficerGrand Prairie, TX
Victor MillerExecutive OfficerPalo Alto, CA
JOHN CLARKExecutive OfficerLexington, TN
Bryant FongDirectorGrand Prairie, TX
Mark TenglerExecutive OfficerGrand Prairie, TX
Steven LutzExecutive OfficerGrand Prairie, TX
Carolyn SikesExecutive OfficerGrand Prairie, TX
Arlen EwartExecutive OfficerGrand Prairie, TX
Russ McMahenExecutive OfficerGrand Prairie, TX
Stacie SwitzerExecutive OfficerGrand Prairie, TX
Margaret CabanoExecutive OfficerGrand Prairie, TX
Greg RobitailleDirectorGrand Prairie, TX
Richard EisenstadtExecutive OfficerGrand Prairie, TX
Alan HellerDirectorGrand Prairie, TX
Asif MughalExecutive OfficerGrand Prairie, TX
Ralph IannelliDirectorGrand Prairie, TX
Vipin GargDirectorGrand Prairie, TX
Vipin GargExecutive OfficerGrand Prairie, TX
Edward SchnipperDirectorGrand Prairie, TX
Dorothy EngelkingExecutive OfficerGrand Prairie, TX

Other filings by this issuer (10)

FiledFormOfferingSold
2015-02-20D/A$20.6M$20.6M
2015-01-07D$15.0M$8.0M
2014-04-09D$2.5M$2.5M
2014-03-04D/A$15.5M$15.5M
2014-01-02D$15.0M$8.1M
2012-07-16D$30.0M$18.3M
2009-11-23D/A$50.0M$24.2M
2009-10-07D/A$40.0M$19.2M
2009-10-07D/A$40.0M$19.1M
2009-07-02D$40.0M$14.6M

More